Penthrox: Second Order for UK and Ireland
2 March 2017
ASX ANNOUNCEMENT
Penthrox: Second order for UK and Ireland
Medical Developments International Limited (ASX: MVP) advises it received a large second order for Penthrox from its partner Galen Pharmaceuticals Ltd (Galen) for the United Kingdom (UK) and Republic of Ireland (Ireland).
MVP CEO, Mr. John Sharman, said: “We are buoyed by the size of the order and its timing, but more so by the momentum building in the UK and Ireland.”
Please refer to the attached for the full release Penthrox – Second order for UK and Ireland